No open-market buys or sells in this period. The transactions below are grants, option exercises and gifts, which carry no market price.
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 90d
-
MIRM Grant·A
Director
$0
5.8K sh · 2 lots
Own New
-
PCRX Grant·A
Director
$0
10.9K sh
Own New
-
PCRX Grant·A
Director
$0
6.4K sh
Own +27%
-
EWTX Grant·A
Director
$0
16.4K sh
Own New
-
ACAD Grant·A
Director
$0
25.3K sh · 2 lots
Own New
-
ACAD Exercise·M
Director
$0
8.1K sh
Own New
-
ACAD Exercise·M
Director
—
8.1K sh
Own +54%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | MIRM | Grant A | 5.8K2 lots | $0 |
| Jun 10, 2026 | PCRX | Grant A | 10.9K | $0 |
| Jun 10, 2026 | PCRX | Grant A | 6.4K | $0 |
| Jun 5, 2026 | EWTX | Grant A | 16.4K | $0 |
| May 29, 2026 | ACAD | Grant A | 25.3K2 lots | $0 |
| May 29, 2026 | ACAD | Exercise M | 8.1K | $0 |
| May 29, 2026 | ACAD | Exercise M | 8.1K | — |
Buy Sell Non-market (grant · exercise · gift)
About Brege Laura
This profile aggregates every SEC Form 4 insider transaction reported by Brege Laura across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.